BrainsWay
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 Hartum St, Jerusalem, Jerusalem, 9777...Phone Number
+972 25824030Website
www.brainsway.comRevenue
$49.1 MillionStock Symbol
BWAYIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About BrainsWay
BrainsWay is an international medical device company founded in 2003 and headquartered in Jerusalem, Israel, specializing as a global leader in advanced noninvasive neurostimulation treatments for mental health disorders using its proprietary Deep Transcranial Magnetic Stimulation platform technology. The company utilizes Deep Transcranial Magnetic Stimulation with unique patented technology developed in collaboration with the National Institute of Health. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies, with current indications including major depressive disorder, including reduction of anxiety symptoms commonly referred to as anxious depression, obsessive-compulsive disorder, and smoking addiction. The Deep TMS platform technology is also used for treatment of bipolar disorders, post traumatic stress disorders, schizophrenia, chronic pain, and other neurological and psychiatric conditions. The company serves doctors, hospiRead more
BrainsWay Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BrainsWay your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BrainsWay had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BrainsWay recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BrainsWay has new funding data
Check if BrainsWay has recently received funding, and reach out quickly before it becomes old news!
BrainsWay, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at BrainsWay
Product Launch: Get notified when BrainsWay launches new products
Check out if BrainsWay is spiking on competitors!
Recommended Actions
Find VP level buyers at BrainsWay
Find more new buyers
Company Profile Activity
Activity Insights
BrainsWay is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BrainsWay is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BrainsWay.
BrainsWay financials insights
Gather financial insights about BrainsWay, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$20M
BrainsWay Tech Stack
A closer look at the technologies used by BrainsWay
Most Recent Scoops
Project
Spending/Investment
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Person-Based
BrainsWay News & Media
Deals: BrainsWay Makes Investment in Hopemark Health; TimelyCare Raises $2.7M After ...
This is an exclusive BHB+ story. BrainsWay Invests in Chicago Area Provider Hopemark Health BrainsWay (Nasdaq: BWAY), the Burlington,BrainsWay Announces Minority-Stake Investment in Hopemark Health
Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative care Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative careBrainsway Q1 Earnings Call Highlights
Brainsway (NASDAQ:BWAY) reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its recurring revenue base. Chief Executive Officer Hadar Levy said on the company’s earnings call that revBrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
Revenue grew approximately 35% year-over-year to $15.5 million for Q1 2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BrainsWay
Sign Up For FreeTo access detailed company insights
BrainsWay is an international medical device company founded in 2003 and headquartered in Jerusalem, Israel, specializing as a global leader in advanced noninvasive neurostimulation treatments for mental health disorders using its proprietary Deep Transcranial Magnetic Stimulation platform technology. The company utilizes Deep Transcranial Magnetic... Read More
